TLR8 and systemic lupus erythematosus: Moreover, the use of miR-21 in EVs as signalling molecules to activate the TLR8 pathway has provided a breakthrough that this pathway has an effect on the disease progression of SLE, and inhibiting it will result in reducing the disease amelioration [59].